Full-Time

Director – Medicinal Chemistry

Confirmed live in the last 24 hours

Kymera Therapeutics

Kymera Therapeutics

201-500 employees

Develops targeted protein degradation therapies

Biotechnology
Healthcare

Senior, Expert

Belmont, MA, USA

Category
Bioinformatics
Computational Biology
Genomics
Public Health
Biology Lab & Research
Biology & Biotech
Required Skills
Data Analysis
Requirements
  • PhD in organic/medicinal chemistry with 8+ years of experience as a medicinal chemist/project leader in the biotech/pharmaceutical industry with a track-record of leading/contributing to research projects towards IND-track nomination
  • Extensive knowledge of modern medicinal chemistry strategies for the optimization of DMPK, biochemical, pharmacological and safety
  • Excellent synthetic organic chemistry skills and creativity are required
  • Proven ability as chemistry leader, contributing beyond med chem as part of a multi-disciplinary project team
  • Proven ability as chemistry leader on validating or prioritizing targets with conclusive data package
  • Demonstrated ability to work collaboratively with cross-functional teams
  • Willingness to be both a strategic leader and a hands-on problem solver
  • Excellent organizational skills, ability to multi-task in an extremely fast-paced environment with changing priorities while maintaining attention to detail
  • Ability to communicate clearly and concisely with all stakeholders
Responsibilities
  • Drive state-of-the-art multi-parameter medicinal chemistry optimization with creativity, innovation, in-depth analysis of data, and existing literature information
  • Contribute in a very impactful manner to compound design and synthetic route identification for all portfolio projects
  • Lead medicinal chemistry efforts on validating targets at early stage to clear decision point
  • Holistic approach to hit/lead finding including use of structure-based drug design and fragment-based drug discovery
  • Effective leadership and management of CRO chemistry teams through excellent synthetic and medicinal chemistry skills with clear and open communication
  • Lead medicinal chemistry efforts and contribute beyond med chem as part of a multi-disciplinary project team
  • Represent the company effectively in scientific matters to external organizations
  • Provide mentorship, guidance, and development for junior project leaders and medicinal chemists

Kymera Therapeutics develops treatments by targeting and breaking down specific proteins that contribute to diseases, particularly cancer and immune disorders. Their main technology, the Pegasus Platform, enables them to identify these harmful proteins and create drug candidates aimed at effectively treating various conditions. Unlike many competitors, Kymera focuses on targeted protein degradation, which can lead to more precise therapies. The company's goal is to create next-generation medicines that address unmet medical needs, supported by partnerships with organizations like Sanofi to enhance their research and development efforts.

Company Stage

IPO

Total Funding

$191.6M

Headquarters

Cambridge, Massachusetts

Founded

2016

Growth & Insights
Headcount

6 month growth

0%

1 year growth

-1%

2 year growth

16%
Simplify Jobs

Simplify's Take

What believers are saying

  • Kymera's recent $275 million public offering provides substantial capital to advance their clinical programs and expand their pipeline.
  • The FDA Fast Track designation for KT-333 could accelerate its development and bring it to market faster, benefiting patients with relapsed/refractory lymphomas.
  • Positive data from ongoing cancer drug trials and the unveiling of KT-294 highlight Kymera's potential for significant breakthroughs in oncology and immunology.

What critics are saying

  • The high costs and long timelines associated with biopharmaceutical R&D could strain Kymera's financial resources despite recent funding.
  • Dependence on partnerships, such as with Sanofi, introduces risks related to collaboration dynamics and milestone achievements.

What makes Kymera Therapeutics unique

  • Kymera Therapeutics leverages its proprietary Pegasus Platform for targeted protein degradation, setting it apart from traditional drug development approaches.
  • Their strategic partnership with Sanofi underscores their credibility and enhances their research capabilities, unlike smaller biotech firms with limited collaborations.
  • Kymera's focus on developing first-in-class therapies for cancer and immune disorders positions them uniquely in the biopharmaceutical market.

Help us improve and share your feedback! Did you find this helpful?